Related by context. Frequent words. (Click for all words.) 69 liposomal formulation 68 hypoxia inducible factor 68 selective inhibitor 66 Recombinant Human 66 small molecule inhibitor 66 induces apoptosis 66 vascular disrupting agent 66 Phosphorylation 65 targeting CD# 65 polymerase inhibitor 65 MEK inhibitor 65 selectively inhibits 65 multi kinase inhibitor 64 PI3 kinase 64 Monoclonal Antibody 64 Preclinical Data 64 JAK1 64 Lenalidomide 64 Voreloxin 64 Inhibits 64 Vascular Endothelial Growth 64 Factor VIIa 63 refractory chronic lymphocytic 63 Epithelial 63 Dasatinib 63 FGFR 63 P#X# 63 Phase III Clinical Trial 63 HCV protease 63 humanized anti 63 Pivotal Phase III 63 sphingosine 1 63 N methyl 63 orally bioavailable 63 proteasome inhibitor 63 Small Molecule 62 J Am Acad 62 Aurora kinase 62 TLR9 agonist 62 tyrosine kinase inhibitor 62 Phase Ib II 62 optical biosensors 62 Inhibitor 62 Polymorphism 62 CYC# 62 mTOR inhibitor 62 J Biol Chem 62 kinesin spindle protein 62 phosphoinositide 3 62 Tesetaxel 62 EZN 62 Bortezomib 61 immune modulator 61 Epratuzumab 61 Nephrol 61 immunomodulator 61 receptor tyrosine kinase 61 EGF receptor 61 induce apoptosis 61 Completes Enrollment 61 Denufosol 61 Carfilzomib 61 potent inhibitor 61 Abstract Number 61 OXi# 61 drug conjugate 61 J Am Soc 61 Pivotal Trial 61 Metastatic Melanoma 61 Vandetanib 61 kinase inhibitor 61 Initiate Phase 61 Initiates Phase 61 J Am Coll 61 osteoblast 61 BAL# [001] 61 androgen independent 61 partial agonist 61 proteasome inhibitors 61 novel orally administered 61 DAVANAT 61 Clinical Trial Results 61 cytostatic 61 Aliskiren 60 Panzem R 60 FLT3 60 SCH # 60 MKC# 60 Survivin 60 humanized monoclonal antibody 60 induced apoptosis 60 selectively inhibit 60 ErbB 60 murine model 60 cyclooxygenase 2 60 MicroRNA 60 VEGFR2 60 Ambrisentan 60 IMC A# 60 THERAPEUTICS 60 II Clinical Trial